TrialSite News recently covered some University of Kentucky Markey Cancer Center news involving a patient who had a colon cancer spread throughout the body. Dr. Villano found out about the case and was able to open an arm of a Phase I first-in-man clinical trial for an investigational new product called BXQ-350. The study has literally saved the patient’s life. We celebrate heroes such as Dr. Villano and the supporting staff that work tirelessly day and night to save lives.
John L. Villano specializes in the treatment of brain cancers. He will advance UK HealthCare’s Clinical Neuro-Oncology Research Program, serving as its director. UK HealthCare has a history of being a world-class neuro-oncology program, and he will help carry this tradition into the future.
Previously, Dr. Villano served as the director of medical neuro-oncology at the University of Illinois Medical Center. He earned a medical degree and doctor of philosophy at the University of Texas Southwestern Medical School at Dallas and trained in neurology at the University of Michigan. He also completed a fellowship in hematology/oncology at the University of Chicago. He is a former American Society of Clinical Oncology track leader for CNS tumors. Currently, he is on the board of the Central Brain Tumor Registry US. He is also a member of the Neuro-Oncology Committee in the cooperative group ALLIANCE and a Society of Neuro-Oncology committee member.